撰文丨王聪编辑丨王多鱼排版丨水成文病理激活的免疫抑制性中性粒细胞会削弱癌症免疫疗法的疗效。趋化因子受体 CXCR4 是造血和中性粒细胞生物学的核心调控因子，是一个颇具吸引力的癌症治疗靶点。2025 年 6 月 26 日，哥伦比亚大学 Timothy ...

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, offering patients an alternative to chemotherapy and surgery.

Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like allergy drugs to fight it.

Observational studies linking bowel cancer to a variety of non-hereditary factors including obesity, alcohol intake and low physical activity have not uncovered anything unique to early-onset cases.